Fellowship · Galveston, TX
Sponsored by University of Texas Medical Branch Hospitals
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.
JAMA dermatology · 2024 · 56 citations · Angela Moore
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
Journal of the American Academy of Dermatology · 2024 · 36 citations · Angela Moore
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
JAMA · 2022 · 98 citations · Angela Moore
Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin.
The oncologist · 2022 · 126 citations · Anisha Patel
Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation.
International journal of dermatology · 2024 · 16 citations · Angela Moore
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents.
The New England journal of medicine · 2025 · 24 citations · Angela Moore
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.
Dermatology and therapy · 2023 · 22 citations · Angela Moore
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials.
American journal of clinical dermatology · 2023 · 55 citations · Angela Moore